In conclusion, this study emphasizes the significance of EPHB1-GSK3B-SMAD3 signaling in PRAD progression and provides a new theoretical basis and experimental support for future studies on the molecular mechanism of PRAD and the development of clinical treatment strategies for cancer. The gene discussed is GSK3B; the disease is cancer.